Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?

BACKGROUND: Rifamycins are a group of antibiotics mainly used in the treatment of tuberculosis (TB), however they interact with antiretroviral therapy (ART). Rifabutin allows more regimens options for concomitant imunodeficiency virus (HIV) treatment compared to rifampicin. OBJECTIVE: Compare the ou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mem Inst Oswaldo Cruz
Hauptverfasser: Schmaltz, Carolina Arana Stanis, Demitto, Fernanda de Oliveira, Sant’Anna, Flavia Marinho, Rolla, Valeria Cavalcanti
Format: Artigo
Sprache:Inglês
Veröffentlicht: Instituto Oswaldo Cruz, Ministério da Saúde 2019
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6372173/
https://ncbi.nlm.nih.gov/pubmed/30758392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/0074-02760180420
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge